Sign In
Buy SGHT
$4.34
+0 (+0%)
At Close: Jun 03, 2026
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance
04:05pm, Wednesday, 05'th Mar 2025
MENLO PARK, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
Will Sight Sciences, Inc. (SGHT) Report Negative Earnings Next Week? What You Should Know
11:05am, Wednesday, 26'th Feb 2025
Sight Sciences (SGHT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A Meta-Analysis of 22 Studies, and Data from the IRIS® Registry Highlighting Clinical Outcomes in Real-World Clinical Practice, Demonstrates Significant, Long-Term IOP Reduction and Medication Reduct
Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025
04:05pm, Wednesday, 19'th Feb 2025
MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercia
Sight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access Day
04:05pm, Thursday, 13'th Feb 2025
MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercia
Budget impact analysis published in the Expert Review of Ophthalmology journal Budget impact analysis published in the Expert Review of Ophthalmology journal
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
04:05pm, Tuesday, 19'th Nov 2024
MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing i
Sight Sciences, Inc. (SGHT) Q3 2024 Earnings Call Transcript
01:32pm, Saturday, 09'th Nov 2024
Sight Sciences, Inc. (NASDAQ:SGHT ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Philip Trip Taylor - Investor Relations Paul Badawi - Co-Founder & Chief Executive
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates
08:06pm, Thursday, 07'th Nov 2024
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.27 per share a year ago.
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024
04:05pm, Thursday, 17'th Oct 2024
MENLO PARK, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercia
The study found improvements in reading speed, vision-related quality of life, and suggested potential benefits of an interventional approach for patients with dry eye disease The study found improvem
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
04:05pm, Tuesday, 20'th Aug 2024
MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing i
Sight Sciences, Inc. (SGHT) Q2 2024 Earnings Call Transcript
03:12am, Saturday, 03'rd Aug 2024
Sight Sciences, Inc. (NASDAQ:SGHT ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Philip Trip Taylor - Investor Relations Paul Badawi - Co-Founder and Chief Executive
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
07:45pm, Thursday, 01'st Aug 2024
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago.
Sight Sciences to Report Second Quarter Financial Results on August 1, 2024
04:05pm, Thursday, 18'th Jul 2024
MENLO PARK, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercia
